Global Surgical Anti-Adhesion Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Surgical Anti-Adhesion Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Surgical Anti-Adhesion Market Size Growth Rate by Product
  • 1.4.2 Gels
  • 1.4.3 Films
• 1.5 Market by End User
  • 1.5.1 Global Surgical Anti-Adhesion Market Size Growth Rate by End User
  • 1.5.2 General/abdominal Surgery
  • 1.5.3 Pelvic/gynecological Surgery
  • 1.5.4 Other Surgery
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Surgical Anti-Adhesion Market Size
  • 2.1.1 Global Surgical Anti-Adhesion Revenue 2014-2025
  • 2.1.2 Global Surgical Anti-Adhesion Sales 2014-2025
• 2.2 Surgical Anti-Adhesion Growth Rate by Regions
  • 2.2.1 Global Surgical Anti-Adhesion Sales by Regions
  • 2.2.2 Global Surgical Anti-Adhesion Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Surgical Anti-Adhesion Sales by Manufacturers
  • 3.1.1 Surgical Anti-Adhesion Sales by Manufacturers
  • 3.1.2 Surgical Anti-Adhesion Sales Market Share by Manufacturers
  • 3.1.3 Global Surgical Anti-Adhesion Market Concentration Ratio (CR5 and HHI)
• 3.2 Surgical Anti-Adhesion Revenue by Manufacturers
  • 3.2.1 Surgical Anti-Adhesion Revenue by Manufacturers (2014-2019)
  • 3.2.2 Surgical Anti-Adhesion Revenue Share by Manufacturers (2014-2019)
• 3.3 Surgical Anti-Adhesion Price by Manufacturers
• 3.4 Surgical Anti-Adhesion Manufacturing Base Distribution, Product Types
  • 3.4.1 Surgical Anti-Adhesion Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Surgical Anti-Adhesion Product Type
  • 3.4.3 Date of International Manufacturers Enter into Surgical Anti-Adhesion Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Surgical Anti-Adhesion Sales by Product
• 4.2 Global Surgical Anti-Adhesion Revenue by Product
• 4.3 Surgical Anti-Adhesion Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Surgical Anti-Adhesion Breakdown Data by End User

6 North America

• 6.1 North America Surgical Anti-Adhesion by Countries
  • 6.1.1 North America Surgical Anti-Adhesion Sales by Countries
  • 6.1.2 North America Surgical Anti-Adhesion Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Surgical Anti-Adhesion by Product
• 6.3 North America Surgical Anti-Adhesion by End User

7 Europe

• 7.1 Europe Surgical Anti-Adhesion by Countries
  • 7.1.1 Europe Surgical Anti-Adhesion Sales by Countries
  • 7.1.2 Europe Surgical Anti-Adhesion Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Surgical Anti-Adhesion by Product
• 7.3 Europe Surgical Anti-Adhesion by End User

8 Asia Pacific

• 8.1 Asia Pacific Surgical Anti-Adhesion by Countries
  • 8.1.1 Asia Pacific Surgical Anti-Adhesion Sales by Countries
  • 8.1.2 Asia Pacific Surgical Anti-Adhesion Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Surgical Anti-Adhesion by Product
• 8.3 Asia Pacific Surgical Anti-Adhesion by End User

9 Central & South America

• 9.1 Central & South America Surgical Anti-Adhesion by Countries
  • 9.1.1 Central & South America Surgical Anti-Adhesion Sales by Countries
  • 9.1.2 Central & South America Surgical Anti-Adhesion Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Surgical Anti-Adhesion by Product
• 9.3 Central & South America Surgical Anti-Adhesion by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Surgical Anti-Adhesion by Countries
  • 10.1.1 Middle East and Africa Surgical Anti-Adhesion Sales by Countries
  • 10.1.2 Middle East and Africa Surgical Anti-Adhesion Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Surgical Anti-Adhesion by Product
• 10.3 Middle East and Africa Surgical Anti-Adhesion by End User

11 Company Profiles

• 11.1 Ethicon
  • 11.1.1 Ethicon Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Ethicon Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Ethicon Surgical Anti-Adhesion Products Offered
  • 11.1.5 Ethicon Recent Development
• 11.2 SANOFI
  • 11.2.1 SANOFI Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 SANOFI Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 SANOFI Surgical Anti-Adhesion Products Offered
  • 11.2.5 SANOFI Recent Development
• 11.3 Baxter International
  • 11.3.1 Baxter International Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Baxter International Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Baxter International Surgical Anti-Adhesion Products Offered
  • 11.3.5 Baxter International Recent Development
• 11.4 Pathfinder Cell Therapy
  • 11.4.1 Pathfinder Cell Therapy Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Pathfinder Cell Therapy Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Pathfinder Cell Therapy Surgical Anti-Adhesion Products Offered
  • 11.4.5 Pathfinder Cell Therapy Recent Development
• 11.5 Covidien
  • 11.5.1 Covidien Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Covidien Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Covidien Surgical Anti-Adhesion Products Offered
  • 11.5.5 Covidien Recent Development
• 11.6 Integra Life Sciences
  • 11.6.1 Integra Life Sciences Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Integra Life Sciences Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Integra Life Sciences Surgical Anti-Adhesion Products Offered
  • 11.6.5 Integra Life Sciences Recent Development
• 11.7 FzioMed
  • 11.7.1 FzioMed Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 FzioMed Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 FzioMed Surgical Anti-Adhesion Products Offered
  • 11.7.5 FzioMed Recent Development
• 11.8 Anika Therapeutics
  • 11.8.1 Anika Therapeutics Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Anika Therapeutics Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Anika Therapeutics Surgical Anti-Adhesion Products Offered
  • 11.8.5 Anika Therapeutics Recent Development
• 11.9 Bioscompass
  • 11.9.1 Bioscompass Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Bioscompass Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Bioscompass Surgical Anti-Adhesion Products Offered
  • 11.9.5 Bioscompass Recent Development
• 11.10 Shanghai Haohai
  • 11.10.1 Shanghai Haohai Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Shanghai Haohai Surgical Anti-Adhesion Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Shanghai Haohai Surgical Anti-Adhesion Products Offered
  • 11.10.5 Shanghai Haohai Recent Development
• 11.11 SJZ Yishengtang
• 11.12 Singclean Medical
• 11.13 SJZ Ruinuo
• 11.14 HK Wellife

12 Future Forecast

• 12.1 Surgical Anti-Adhesion Market Forecast by Regions
  • 12.1.1 Global Surgical Anti-Adhesion Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Surgical Anti-Adhesion Revenue Forecast by Regions 2019-2025
• 12.2 Surgical Anti-Adhesion Market Forecast by Product
  • 12.2.1 Global Surgical Anti-Adhesion Sales Forecast by Product 2019-2025
  • 12.2.2 Global Surgical Anti-Adhesion Revenue Forecast by Product 2019-2025
• 12.3 Surgical Anti-Adhesion Market Forecast by End User
• 12.4 North America Surgical Anti-Adhesion Forecast
• 12.5 Europe Surgical Anti-Adhesion Forecast
• 12.6 Asia Pacific Surgical Anti-Adhesion Forecast
• 12.7 Central & South America Surgical Anti-Adhesion Forecast
• 12.8 Middle East and Africa Surgical Anti-Adhesion Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Surgical Anti-Adhesion Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details